Page last updated: 2024-08-16

sulforaphane and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

sulforaphane has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, WY; Kung, PH; Kuo, CY; Wu, CC1

Other Studies

1 other study(ies) available for sulforaphane and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

ArticleYear
Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway.
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Calcium; Cattle; Enzyme Activation; Humans; Isothiocyanates; Phosphatidylinositol 3-Kinases; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Proto-Oncogene Proteins c-akt; Receptor, PAR-1; Signal Transduction; Sulfoxides; Thromboxane A2; Tyrosine; Vasoconstrictor Agents; Vegetables

2013